Patents by Inventor Hitesh Sanganee

Hitesh Sanganee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemical compounds
    Publication number: 20050171092
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
    Type: Application
    Filed: March 10, 2005
    Publication date: August 4, 2005
    Inventors: Aaron Rigby, Hitesh Sanganee, Brian Springthorpe, Louise Lawrence
  • Novel substituted indoles
    Publication number: 20050165055
    Abstract: The present invention relates to substituted indoles of formula (I) useful as pharmaceutical compounds for treating respiratory disorders.
    Type: Application
    Filed: May 27, 2003
    Publication date: July 28, 2005
    Inventors: Roger Bonnert, Stephen Brough, Tony Cook, Mark Dickinson, Rukhsana Rasul, Hitesh Sanganee, Simon Teague
  • Bipiperidine compounds
    Patent number: 6903115
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
    Type: Grant
    Filed: January 13, 2003
    Date of Patent: June 7, 2005
    Assignee: AstraZeneca AB
    Inventors: Aaron Rigby, Hitesh Sanganee, Brian Springthorpe, Louise Lawrence
  • Piperdine derivatives and their use as modulators of chemokine (especially ccr3) activity
    Publication number: 20040242577
    Abstract: The invention provides a compound of formula (I): T is C(O) or S(O)2; W is CH2, (CH2)2, CH(CH3), CH(CH3)O or cyclopropyl; X is O, CH2, C(O), S, S(O), S(O)2 or NR3; m is 0 or 1; R1 is optionally substituted aryl or optionally substituted heterocyclyl; R2 is alkyl (optionally substituted by OH), cycloalkyl, optionally substituted aryl or optionally substituted heterocyclyl; that are modulators of chemokine (especially CCR3) activity and are especially useful for treating asthma and/or rhinitis.
    Type: Application
    Filed: March 17, 2004
    Publication date: December 2, 2004
    Inventors: Hitesh Sanganee, Brian Springthorpe
  • Chemical compounds
    Publication number: 20040102432
    Abstract: The invention provides compounds of formula (I): as modulators of chemokine and H1 receptor activity. The compounds are especially useful in the treatment of asthma and rhinitis.
    Type: Application
    Filed: February 13, 2003
    Publication date: May 27, 2004
    Inventors: Hitesh Sanganee, Brian Springthorpe
  • Chemical compounds
    Publication number: 20040014783
    Abstract: The present invention provides a compound of a formula (I): 1
    Type: Application
    Filed: May 13, 2003
    Publication date: January 22, 2004
    Applicant: AstraZeneca AB, a Sweden corporation
    Inventors: Aaron Rigby, Hitesh Sanganee, Brian Springthorpe, Louise Lawrence
  • Chemical compounds
    Publication number: 20040006080
    Abstract: The present invention provides a compound of a formula (I): 1
    Type: Application
    Filed: January 13, 2003
    Publication date: January 8, 2004
    Applicant: AstraZeneca AB, a Sweden corporation
    Inventors: Aaron Rigby, Hitesh Sanganee, Brian Springthorpe, Louise Lawrence
  • Chemical compounds
    Publication number: 20030166652
    Abstract: The invention concerns compounds of formula (I), and their use in therapy, particularly in the modulation of CCR3 activity.
    Type: Application
    Filed: November 20, 2002
    Publication date: September 4, 2003
    Inventors: Hitesh Sanganee, Brian Springthorpe
  • Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists
    Patent number: 6525070
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
    Type: Grant
    Filed: April 6, 2001
    Date of Patent: February 25, 2003
    Assignee: AstraZeneca AB
    Inventors: Aaron Rigby, Hitesh Sanganee, Brian Springthorpe, Louise Lawrence
  • Chemical compounds
    Publication number: 20020077337
    Abstract: The present invention provides a compound of a formula (I): 1
    Type: Application
    Filed: April 6, 2001
    Publication date: June 20, 2002
    Inventors: Aaron Rigby, Hitesh Sanganee, Brian Springthorpe, Louise Lawrence